Search

Jonathan Robert Moll

from Columbia, MD
Age ~63
Get Report
Also known as:
Jonathan R Moll, Jon R Moll, John R Moll, Robert Moll
Related to:
Gerlad MollLinda Schroeder, 83Michael T Waters, 56Tina Eytcheson, 57Janice White, 73
Connected to:
Amanda Moll, 37Christi E Moll, 52Corrie Moll, 33Darlene S Moll, 71Devan A Moll, 34Eric A Moll, 46Eugene E Moll, 60Hannah F Moll, 31Hiram D Moll, 68Jason S Moll, 50

Jonathan Moll Phones & Addresses

  • Columbia, MD
  • Frederick, MD
  • 7737 Epsilon Pl, Derwood, MD 20855 (240) 683-9856
  • Rockville, MD
  • Cabin John, MD
  • Bethesda, MD
  • Charlottesville, VA
  • Saginaw, MI

Work

Company: Canon us life sciences Sep 2010 Address: Rockville, MD Position: R&d manager

Education

Degree: Ph.D. School / High School: University of Virginia 1997 Specialities: Biology

Industries

Biotechnology

Resumes

Resumes

Jonathan Moll Photo 1

R&D Manager At Canon Us Life Sciences

View page
Position:
R&D Manager at Canon US Life Sciences
Location:
Washington D.C. Metro Area
Industry:
Biotechnology
Work:
Canon US Life Sciences - Rockville, MD since Sep 2010
R&D Manager
Adlyfe, Inc Sep 2007 - Sep 2010
Senior Research Scientist
Human Genome Sciences Jun 2001 - Aug 2007
Senior Scientist I
National Cancer Institute, NIH Sep 1997 - May 2001
Postdoctoral Fellow
University of Virginia Sep 1991 - Sep 1997
Graduate Student
Education:
University of Virginia 1997
Ph.D., Biology University of Michigan 1986
B. Sci., Biology

Publications

Us Patents

Detection And Treatment Of Traumatic Brain Injury

View page
US Patent:
20120282169, Nov 8, 2012
Filed:
Nov 4, 2010
Appl. No.:
13/508212
Inventors:
D. Roxanne Duan - Bethesda MD, US
Jonathan R. Moll - Rockville MD, US
Alan Rudolph - Potomac MD, US
International Classification:
G01N 21/64
A61K 51/00
A61K 49/06
A61K 49/00
US Classification:
424 111, 436501, 435 78, 424 96, 424 93, 424 95, 424 91
Abstract:
The present invention relates to the detection of traumatic brain injury by detecting Aβ protein aggregates associated with traumatic brain injury. These Aβ protein aggregates are detected using peptide and peptide mimic probes that preferentially associate with Aβ protein aggregates associated with traumatic brain injury.

Stabilized Amyloid-Beta Oligomers And Uses Thereof

View page
US Patent:
20130274437, Oct 17, 2013
Filed:
May 24, 2011
Appl. No.:
13/698857
Inventors:
Roxanne Duan - Bethesda MD, US
Jonathan Moll - Rockville MD, US
Alan S. Rudolph - Potomac MD, US
International Classification:
C07K 14/47
C07K 1/14
US Classification:
530324
Abstract:
The present invention pertains to stabilized Aβ oligomer compositions. Methods for generating stabilized Aβ oligomer compounds are also provided herein. Additionally, screening assays employing the Aβ oligomer compounds and methods for generating therapeutics with the Aβ oligomers are also provided. In a particular embodiment, the Aβ oligomer described herein is comprised of Aβ42 peptide.

Conformationally Dynamic Peptides

View page
US Patent:
20100233095, Sep 16, 2010
Filed:
Jan 28, 2010
Appl. No.:
12/695968
Inventors:
D. Roxanne Duan - Bethesda MD, US
Jonathan R. Moll - Rockville MD, US
Alan Rudolph - Potomac MD, US
Renee Wegrzyn - Washington DC, US
International Classification:
A61K 49/04
C07K 7/06
C07K 7/08
C07K 14/00
G01N 33/53
A61K 49/14
A61K 49/22
A61K 38/08
A61K 38/10
A61K 38/16
A61P 25/28
A61P 25/16
US Classification:
424 934, 530328, 530327, 530326, 530325, 530324, 436501, 424 94, 424 95, 514 15, 514 14, 514 13, 514 12
Abstract:
Disclosed are novel peptides that are useful, for example, for detecting target proteins having a β-sheet secondary structure which may be associated with a disease, and for diagnosing and treating such a disease. Related methods and kits also are disclosed.

Conformationally Dynamic Peptides

View page
US Patent:
20150133632, May 14, 2015
Filed:
Jun 9, 2014
Appl. No.:
14/299432
Inventors:
D. Roxanne Duan - Bethesda MD, US
Jonathan R. Moll - Rockville MD, US
Alan Rudolph - Potomac MD, US
Renee Wegrzyn - Washington DC, US
Assignee:
Adlyfe, Inc. - Rockville MD
International Classification:
G01N 33/58
C07K 19/00
C07K 14/00
US Classification:
530324, 530326
Abstract:
Disclosed are novel peptides that are useful, for example, for detecting target proteins having a β-sheet secondary structure which may be associated with a disease, and for diagnosing and treating such a disease. Related methods and kits also are disclosed.
Control profile
Jonathan Robert Moll from Columbia, MD, age ~63 Get Report